An Ongoing First-In-Human Phase 1 Trial Of Nx-5948, An Oral Bruton'S Tyrosine Kinase (Btk) Degrader, In Patients With Relapsed/Refractory B Cell Malignancies
NX-5948
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: An Ongoing First-In-Human Phase 1 Trial Of Nx-5948, An Oral Bruton'S Tyrosine Kinase (Btk) Degrader, In Patients With Relapsed/Refractory B Cell Malignancies ### Output: NX-5948